Dr. Hongbing Liu is currently an Assistant Professor in Department of Pediatric Nephrology, Tulane University School of Medicine. Since 1987, Dr. Liu has conducted a broad range of research in a number of different institutes in mainland China, Hong Kong, and USA. In more than a decade, he has been working on genetic and molecular control of mammalian organ development. He is very versed at employing genetic, biochemical, cell biological, and molecular biological approaches to address kidney development issues in mouse model systems. His current research interests mainly focus on the roles of Histone Deacetylases (HDACs) in kidney development and diseases. His studies will provide new insights into the epigenetics of kidney development and open new avenues to novel strategies for the prevention and treatment of kidney diseases and associated renal-cardiovascular diseases, through pharmaceutical agents that target epigenetic modifiers.
Other Editorial Board Members